62
|
237
|
5lezC |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
68
|
213
|
5lf3L |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
55
|
202
|
5lf3N |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
54
|
196
|
5lf7J |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
66
|
239
|
5lf7F |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
59
|
202
|
5leyN |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
73
|
248
|
5lezB |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
53
|
196
|
5lexJ |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
57
|
204
|
5le5I |
Native human 20s proteasome at 1.8 angstrom |
69
|
237
|
5le5C |
Native human 20s proteasome at 1.8 angstrom |
64
|
234
|
5lf0E |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
66
|
216
|
5leyM |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
66
|
213
|
5lexL |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
71
|
248
|
5le5B |
Native human 20s proteasome at 1.8 angstrom |
69
|
213
|
5leyL |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
65
|
200
|
5lf4K |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
54
|
196
|
5leyJ |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
61
|
230
|
5lexA |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
65
|
200
|
5lezK |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
67
|
213
|
5lezL |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
65
|
200
|
5lexK |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
57
|
202
|
5lexN |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
56
|
202
|
5lezN |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
65
|
216
|
5lezM |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
64
|
237
|
5lf1C |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
63
|
200
|
5lf3K |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
66
|
230
|
5lf6A |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
69
|
233
|
5lttM |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
60
|
195
|
5lttJ |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
66
|
250
|
5lttA |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
57
|
202
|
5lf4N |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
73
|
248
|
5lf7B |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
66
|
237
|
5lf3C |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
74
|
248
|
5lf1B |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
62
|
233
|
5lf3D |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
54
|
204
|
5lf7I |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
76
|
248
|
5leyB |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
65
|
200
|
5lf1K |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
67
|
230
|
5lf4A |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
64
|
244
|
5lezG |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
62
|
244
|
5lf6G |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
54
|
204
|
5lf4I |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
62
|
195
|
5l52J |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
58
|
222
|
5l52L |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
72
|
212
|
5l52K |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
70
|
244
|
5l5tB |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
61
|
211
|
5l5dK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
65
|
250
|
5l5fA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
64
|
211
|
5l5rK |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
62
|
231
|
5l54E |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |